Lineage Cell Therapeutics, Inc.’s (LCTX) Moving Averages Convergence Divergence (MACD) indicator is 0.08, suggesting Lineage Cell Therapeutics, Inc. is a Sell.

Lineage Cell Therapeutics, Inc.’s (LCTX) 20-Day exponential moving average is 1.33, while Lineage Cell Therapeutics, Inc.’s (LCTX) share price is $1.47, making it a Buy.

Lineage Cell Therapeutics, Inc.’s (LCTX) 50-Day exponential moving average is 1.23, while Lineage Cell Therapeutics, Inc.’s (LCTX) share price is $1.47, making it a Buy.

Advanced Chart >

Lineage Therap (LCTX) Pivot Points

Apr 25, 2024, 12:20 AM

Classic

1.27

1.33

1.36

1.42

1.45

1.51

1.54

Fibonacci

1.33

1.36

1.38

1.42

1.45

1.47

1.51

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Lineage Therap (LCTX) Moving Averages

Apr 25, 2024, 12:20 AM

MA5

1.41Buy

1.43Buy

MA10

1.40Buy

1.39Buy

MA20

1.32Buy

1.33Buy

MA50

1.17Buy

1.23Buy

MA100

1.11Buy

1.18Buy

MA200

1.21Buy

1.23Buy

Lineage Cell Therapeutics, Inc.’s (LCTX) 10-Day exponential moving average is 1.39, while Lineage Cell Therapeutics, Inc.’s (LCTX) share price is $1.47, making it a Buy.

Lineage Cell Therapeutics, Inc.’s (LCTX) 100-Day exponential moving average is 1.18, while Lineage Cell Therapeutics, Inc.’s (LCTX) share price is $1.47, making it a Buy.

Lineage Cell Therapeutics, Inc.’s (LCTX) stock price is $1.47 and Lineage Cell Therapeutics, Inc.’s (LCTX) 50-day simple moving average is 1.17, creating a Buy signal.

Lineage Cell Therapeutics, Inc.’s (LCTX) stock price is $1.47 and Lineage Cell Therapeutics, Inc.’s (LCTX) 100-day simple moving average is 1.11, creating a Buy signal.

Lineage Cell Therapeutics, Inc.’s (LCTX) stock price is $1.47 and Lineage Cell Therapeutics, Inc.’s (LCTX) 200-day simple moving average is 1.21, creating a Buy signal.

Lineage Therap (LCTX) Technical Indicators

Apr 25, 2024, 12:20 AM

RSI (14)

61.87

Neutral

STOCH (9,6)

52.43

Neutral

STOCHRSI (14)

62.58

Neutral

MACD (12,26)

0.08

Sell

ADX (14)

46.57

Neutral

Williams %R

-30.43

Buy

CCI (14)

102.62

Sell

ATR (14)

0.12

Ultimate Oscillator

50.14

Neutral

ROC

25.64

Buy

Lineage Cell Therapeutics, Inc.’s (LCTX) Relative Strength Index (RSI) is 61.87, creating a Neutral signal.

Lineage Cell Therapeutics, Inc.’s (LCTX) Trend Strength Indicator (ADX) is 46.57, creating a Neutral signal.

Lineage Cell Therapeutics, Inc.’s (LCTX) Commodity Channel Index (CCI) is 102.62, creating a Sell signal.

Lineage Cell Therapeutics, Inc.’s (LCTX) Price Rate of Change (ROC) is 25.64, creating a Buy signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is LCTX a Buy, Hold, or Sell?

Based on LCTX’s technical indicators, LCTX is a Strong Buy.

What is LCTX’s RSI (14)?

LCTX’s RSI (14) is 61.87, which suggests LCTX is a Neutral.

What is LCTX’s MACD?

LCTX’s MACD is 0.08, which suggests LCTX is a Sell.

What is LCTX’s 5-day moving average?

LCTX’s 5-day moving average is 1.41, which suggests LCTX is a Buy.

What is LCTX’s 20-day moving average?

LCTX 20-day moving average is 1.32, which suggests LCTX is a Buy.

What is LCTX’s 50-day moving average?

LCTX’s 50-day moving average is 1.17, which suggests LCTX is a Buy.

What is LCTX’s 200-day moving average?

LCTX’s 200-day moving average is 1.21, which suggests LCTX is a Buy.

What is LCTX’s Williams % R (14)?

LCTX’s Williams % R (14) is -30.43, which suggests LCTX is a Buy.

What is LCTX’s CCI (14)?

LCTX’s CCI (14) is 102.62, which suggests LCTX is a Sell.

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing